Associate Professor
The Chinese University of Hong Kong, Hong Kong
Assistant Dean (Translation & Entrepreneurship)
Associate Professor
SH Ho Urology Centre
The Chinese University of Hong Kong
He is currently:
- Associate Member, EAU Prostate cancer guidelines panel
- President of the Hong Kong Urological Association (HKUA) 2022-26
- Member of the SIU Research council, and Scientific Programme committee
Dr. Peter Chiu graduated from the Faculty of Medicine of the Chinese University of Hong Kong (CUHK) and obtained the fellowship in Urology from the College of Surgeons of Edinburgh. He received post-graduate training on Prostate Cancer research and Andrology in the Erasmus Medical Centre in Rotterdam, The Netherlands, and obtained a PhD degree on Prostate Cancer diagnosis.
His clinical practice and research focus on Prostate cancer, from prostate cancer screening, diagnosis with novel biomarkers (prostate health index, urine spermine), MRI-guided targeted prostate biopsy, to focal therapy. He currently utilizes HIFU, Cryotherapy and Targeted microwave ablation (TMA) as focal therapy for prostate cancer. He also has special interest in managing patients with advanced prostate cancer with novel treatment options.
HT-03: PSMA PET for localised disease
Thursday, October 30, 2025
14:36 - 14:48 GMT+0
Saturday, November 1, 2025
11:15 - 12:45 GMT+0
Saturday, November 1, 2025
11:15 - 11:20 GMT+0
Saturday, November 1, 2025
11:45 - 11:55 GMT+0
Saturday, November 1, 2025
12:10 - 12:25 GMT+0
CO-06: Controversies in Management of Locally Advanced, Recurrent and Metastatic Prostate Cancer
Saturday, November 1, 2025
14:00 - 15:30 GMT+0
CO-06: Neo-adj & adj Rx of CaP being treated surgically
Saturday, November 1, 2025
14:12 - 14:24 GMT+0